Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2025

Supplementary Figure 1 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

View Full Paper
Ask AI
Bookmark
Share

Authors

BTBianca TesiARAnna RobeliusBBBerivan Baskin

Discussion

Loading...

Member takes

Overview

Cohort study validates genetic guidelines for myeloid neoplasms, suggesting improved variant investigation methods.

Key Points

  • This research confirms genetic guidelines for investigating myeloid neoplasms with germline predisposition.
  • A prospective cohort study evaluated the source of germline DNA for whole exome sequencing (WES).
  • Peripheral blood was the primary source for extracting germline DNA used in the genetic tests.
  • These findings may enhance the accuracy of genetic investigations for myeloid neoplasms, benefiting clinical practice.

Cite This Study

Tesi et al. (2025) studied this question.

synapsesocial.com/papers/689a02bce6551bb0af8cc67ahttps://doi.org/10.1158/1078-0432.29568283
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Supplementary Figure 4 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  2. 2Supplementary Figure 5 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  3. 3Data from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  4. 4Supplementary Figure 2 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  5. 5Supplementary Figure 6 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025